Workout
Healthy Eating
Meditation
Podcast
Authenticity
Social Service
About Us
Review Board
Editorial Process
Contact Us
Health Tracker
AI Tools
✔Fact Checked

The Serie A team could give Barcelona a €5 million boost in the January transfer market

Las Palmas centre-back Mika Mármol has been attracting interest more or less since he signed for the club, and the January transfer market will see him again on the short lists. The 23-year-old defender is currently the object of Roma’s attention.

According to Matteo Moretto in Relevo, Roma are interested in Mármol and, despite the links with Sevilla in recent weeks, his information is that Como and the Giallorossi are taking his signing very seriously. The first ones looked at him in the summer and the Las Palmas coach, Miguel Ángel Ramírez, could advance his sale.

Mármol ends his contract in 2026 and has shown little appetite for a contract renewal. Therefore, Las Palmas could try to sell him sooner rather than later, to avoid a situation like that of Álvaro Vallés; although he will not accept less than his termination clause of 10 million euros.

That could be good news for Barcelona, ​​who still retain a 50% resale clause for his move to Andorra. Mármol starred in an impressive Las Palmas defense last season before collapsing down the stretch. In recent months, Diego Martínez has left him out of the side, but Mármol has had playing time at left back.

Last reviewed on

Expert Q&A

Ask a Question
Share Now:

Was this article helpful?

🤓

😕

dotdash removebg preview

FitToFar is part of the Dotdash Meredith publishing family.

Please review our updated Terms of Service.

BE THE FIRST TO KNOW

SUBSCRIBE TO GET LATEST FITNESS AND NUTRITION UPDATES!

We don’t spam! Read our privacy policy for more info.

The FitToFar News team takes pride in providing readers with accurate, properly sourced, and objectively analyzed content. Each news piece is stringently fact-checked by our Integrity Network, and any form of plagiarism or malicious behavior from our authors and contributors is strictly forbidden.

Our articles follow a number of key standards:

  • Each cited research and studies should come from renowned peer-reviewed journals or educational bodies. Additionally, any quoted data and figures must be traceable to its origin, while also detailing their significance.

  • Content related to treatment, medicine, and procedure must plainly specify availability, cost, possible side effects, targets, possible interactions, and unapproved usage (if relevant).

  • Every news article should have inputs from at least two authorized professionals, with corresponding qualifications and ties to appropriate associations or works.

  • The reader must be made aware of any potential conflict of interest relating to the source or study.

  • Finally, all news pieces should be supplied with enough background and context regarding the relevant topic or condition.